Ascletis Pharma Inc (HKEX: 1672), a China-based, R&D driven biotech company, announced on Sunday that it has named John P. Gargiulo as its new chief business officer.
In the new role, Gargiulo is to head the company's corporate business development and alliance management and report to Dr Jinzi J. Wu, PhD, of Ascletis founder, chairman and CEO.
Gargiulo has served as North America president and CEO of Daiichi Sankyo. He has more than 30 years of experience in marketing strategies, business integration and commercial operations in the global pharma/biotech industry. He has served in various positions with increasing responsibility for 18 years at Daiichi Sankyo.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer